FAST vs REGN · P/E 43, rev $7.55B vs P/E 14, rev $14.34B
Fastenal Company (FAST) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FAST and REGN stock pages for the full models.
Not investment advice.